Comparison · NCT02935699-c3aa30bb
Test Drug vs Control: Number of Patients Who Needed to Return to Treatment Center
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Test Drug vs Control: Number of Patients Who Needed to Return to Treatment Center. Trial comparisons, record NCT02935699-c3aa30bb. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02935699-c3aa30bb
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0551 | 0.027 | 0.109 | wilson | |
| Risk in group 2 | 0.141 | 0.092 | 0.209 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0856 | -0.16 | -0.0127 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.392 | 0.17 | 0.9 | log | |
| Odds ratio, group 1 over group 2 | 0.356 | 0.144 | 0.879 | log | |
| Number needed to treat, for one fewer participant with the outcome on Test Drug than on Control | 11.7 | 6.26 | 79 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Test Drug | JDP-205 Injection, 10 mg/mL, 1 mL~Test Drug (JDP-205): JDP-205 Injection, 10 mg/mL, 1 mL | 7 | 127 | OG000 |
| Group 2 | Control | Diphenhydramine Injection, 50 mg/mL, 1 mL~Active Control (Diphenhydramine): Diphenhydramine Injection, 50 mg/mL | 19 | 135 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Patients Who Needed to Return to Treatment Center
- Description
- Number of patients who needed to return to treatment center approximately 24 hours after discharge
- Time frame
- up to 24 hrs
- Population
- Intent To Treat Population
Source ClinicalTrials.gov
Trial
- Title
- Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria
- NCT number
- NCT02935699
- Phases
- PHASE3
- Conditions
- Acute Urticaria
- Interventions
- Test Drug (JDP-205), Active Control (Diphenhydramine)
- Lead sponsor
- JDP Therapeutics, Inc.
- Results first posted
- 2019-11-27
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02935699?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02935699-c3aa30bb